Federated AI for drug discovery
Apheris is a Berlin-based company building federated AI infrastructure for drug discovery, enabling collaborative model training across pharmaceutical partners without sharing raw proprietary data. Public materials highlight federated data networks and superior discovery models. In 2025–2026 Apheris and Ginkgo Datapoints launched an Antibody Developability Consortium with founding pharma members reported in press coverage.
For people
For agents
Nothing listed yet.